Search research articles
Contact Us
Filters
Showing results (131-140 of 148) with videos related to
Page
of 15
Sort By:
Journal of Medicinal Chemistry
|
March 17, 2022
Discovery of Insulin Receptor Partial Agonists MK-5160 and MK-1092 as Novel Basal Insulins with Potential to Improve Therapeutic Index
Dmitri A Pissarnitski, Ahmet Kekec, Lin Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 31, 2017
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
Kyaw L Aung, Sandra E Fischer, Robert E Denroche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
Jennifer J Knox, Grainne O'Kane, Daniel King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2025
Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
Jennifer J Knox, Grainne O'Kane, Daniel King, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination-deficient Pancreatic Cancer
Yifan Wang, Jin Yong Patrick Park, Alain Pacis, et al.
Nature Genetics
|
February 14, 2020
Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution
Michelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, et al.
Blood Advances
|
May 7, 2025
Outcomes of Brexucabtagene Autoleucel in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients with CNS Involvement
Ibrahim N Muhsen, Gregory W Roloff, Rawan G Faramand, et al.
Nature Communications
|
July 2, 2025
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial
Jennifer J Knox, Gun Ho Jang, Robert C Grant, et al.
Transplantation and Cellular Therapy
|
June 27, 2026
Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)
Rawan G Faramand, Amy Zhang, Gregory W Roloff, et al.
Nature Genetics
|
January 15, 2020
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution
Michelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 148) with videos related to
Sort By:
Page
of 15
Journal of Medicinal Chemistry
|
March 17, 2022
Discovery of Insulin Receptor Partial Agonists MK-5160 and MK-1092 as Novel Basal Insulins with Potential to Improve Therapeutic Index
Dmitri A Pissarnitski, Ahmet Kekec, Lin Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 31, 2017
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
Kyaw L Aung, Sandra E Fischer, Robert E Denroche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
Jennifer J Knox, Grainne O'Kane, Daniel King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2025
Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
Jennifer J Knox, Grainne O'Kane, Daniel King, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination-deficient Pancreatic Cancer
Yifan Wang, Jin Yong Patrick Park, Alain Pacis, et al.
Nature Genetics
|
February 14, 2020
Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution
Michelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, et al.
Blood Advances
|
May 7, 2025
Outcomes of Brexucabtagene Autoleucel in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients with CNS Involvement
Ibrahim N Muhsen, Gregory W Roloff, Rawan G Faramand, et al.
Nature Communications
|
July 2, 2025
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial
Jennifer J Knox, Gun Ho Jang, Robert C Grant, et al.
Transplantation and Cellular Therapy
|
June 27, 2026
Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)
Rawan G Faramand, Amy Zhang, Gregory W Roloff, et al.
Nature Genetics
|
January 15, 2020
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution
Michelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, et al.
Page
of 15